Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

PTC Therapeutics patents new compounds for SMA

Oct. 14, 2013

Elan discloses new BACE1 inhibitors for Alzheimer's disease

Oct. 14, 2013

ADN-1184 may improve behavioral and psychological symptoms of dementia

Oct. 14, 2013

Topline results reported from phase II ofatumumab trial in relapsing-remitting MS

Oct. 14, 2013

Sorrento Therapeutics acquires resiniferatoxin for chronic pain

Oct. 14, 2013

QR Pharma and UCLA receive grant to test Posiphen in models of traumatic brain injury

Oct. 14, 2013

Salbutamol beneficial in patients with spinal muscular atrophy

Oct. 14, 2013

Medivir selects a candidate drug for neuropathic pain

Oct. 11, 2013

Alkermes' ALKS-5461 receives fast track designation for major depressive disorder

Oct. 11, 2013

Linx Pharmaceutical reports discovery of apoptosis inhibitors

Oct. 11, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...